pI: 8.2476 |
Length (AA): 126 |
MW (Da): 14552 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 94 | 1rl1 (A) | 138 | 228 | 38.00 | 0 | 0.99 | 1.25952 | -0.72 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127963)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G11260 | phosphatase SGT1b |
Arabidopsis thaliana | AT4G23570 | phosphatase SGT1a |
Brugia malayi | Bm1_21075 | SGS domain containing protein |
Candida albicans | CaO19.11570 | similar to S. cerevisiae SGT1 subunit of SCF ubiquitin ligase complex |
Candida albicans | CaO19.4089 | similar to S. cerevisiae SGT1 subunit of SCF ubiquitin ligase complex |
Caenorhabditis elegans | CELE_D1054.3 | Protein D1054.3, isoform B |
Dictyostelium discoideum | DDB_G0269292 | SGS domain-contantaing protein |
Drosophila melanogaster | Dmel_CG9617 | suppressor-of-G2-allele-of-skp1 |
Echinococcus granulosus | EgrG_001006400 | Suppressor of G2 allele of SKP1 |
Entamoeba histolytica | EHI_117820 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_001006400 | Suppressor of G2 allele of SKP1 |
Giardia lamblia | GL50803_7850 | Sgt1-like protein |
Homo sapiens | 10910 | SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
Leishmania braziliensis | LbrM.20.5800 | phosphatase-like protein |
Leishmania donovani | LdBPK_201610.1 | Suppressor of G2 allele of SKP1, putative |
Leishmania infantum | LinJ.20.1610 | phosphatase-like protein |
Leishmania major | LmjF.20.1640 | phosphatase-like protein |
Leishmania mexicana | LmxM.20.1640 | phosphatase-like protein |
Loa Loa (eye worm) | LOAG_08244 | hypothetical protein |
Mus musculus | ENSMUSG00000022024 | SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
Neospora caninum | NCLIV_031740 | GJ10617, related |
Oryza sativa | 4326682 | Os01g0624500 |
Onchocerca volvulus | OVOC7546 | Putative chaperone binding protein |
Plasmodium berghei | PBANKA_0834000 | calcyclin-binding protein, putative |
Plasmodium falciparum | PF3D7_0933200 | calcyclin-binding protein, putative |
Plasmodium knowlesi | PKNH_0731900 | calcyclin-binding protein, putative |
Plasmodium vivax | PVX_087045 | SGS domain containing protein |
Saccharomyces cerevisiae | YOR057W | Sgt1p |
Schistosoma japonicum | Sjp_0056120 | Suppressor of G2 allele of SKP1 homolog, putative |
Schistosoma mansoni | Smp_010160 | chaperone binding protein |
Schistosoma mansoni | Smp_168350 | chaperone binding protein |
Schmidtea mediterranea | mk4.000280.10 | |
Trypanosoma brucei gambiense | Tbg972.1.1960 | phosphatase-like protein, putative |
Trypanosoma brucei | Tb927.1.3200 | Suppressor of G2 allele of SKP1, putative |
Trypanosoma congolense | TcIL3000_1_1550 | Suppressor of G2 allele of SKP1, putative |
Trypanosoma cruzi | TcCLB.508405.30 | Suppressor of G2 allele of SKP1, putative |
Trypanosoma cruzi | TcCLB.507837.60 | Suppressor of G2 allele of SKP1, putative |
Toxoplasma gondii | TGME49_231590 | SGS domain-containing protein |
Theileria parva | TP04_0559 | hypothetical protein |
Trichomonas vaginalis | TVAG_324510 | chaperone binding protein, putative |
Trichomonas vaginalis | TVAG_078170 | chaperone binding protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.1.3200 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.3200 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.3200 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.1.3200 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_D1054.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
YOR057W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_231590 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.